- Home
- PUBM vs PSNL Comparison
PUBM vs PSNL Comparison
Compare PUBM & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUBM
- PSNL
- Stock Information
- Founded
- PUBM 2006
- PSNL 2011
- Country
- PUBM United States
- PSNL United States
- Employees
- PUBM N/A
- PSNL N/A
- Industry
- PUBM Computer Software: Prepackaged Software
- PSNL Medical Specialities
- Sector
- PUBM Technology
- PSNL Health Care
- Exchange
- PUBM Nasdaq
- PSNL Nasdaq
- Market Cap
- PUBM 515.8M
- PSNL 460.7M
- IPO Year
- PUBM 2020
- PSNL 2019
- Fundamental
- Price
- PUBM $11.09
- PSNL $5.04
- Analyst Decision
- PUBM Buy
- PSNL Strong Buy
- Analyst Count
- PUBM 11
- PSNL 5
- Target Price
- PUBM $22.60
- PSNL $8.00
- AVG Volume (30 Days)
- PUBM 623.5K
- PSNL 748.3K
- Earning Date
- PUBM 05-08-2025
- PSNL 05-06-2025
- Dividend Yield
- PUBM N/A
- PSNL N/A
- EPS Growth
- PUBM N/A
- PSNL N/A
- EPS
- PUBM 0.10
- PSNL N/A
- Revenue
- PUBM $288,380,000.00
- PSNL $85,694,000.00
- Revenue This Year
- PUBM $4.07
- PSNL N/A
- Revenue Next Year
- PUBM $10.05
- PSNL $27.82
- P/E Ratio
- PUBM $111.99
- PSNL N/A
- Revenue Growth
- PUBM 3.62
- PSNL 15.57
- 52 Week Low
- PUBM $7.46
- PSNL $1.14
- 52 Week High
- PUBM $24.50
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- PUBM 67.96
- PSNL 70.29
- Support Level
- PUBM $9.50
- PSNL $3.98
- Resistance Level
- PUBM $10.13
- PSNL $5.61
- Average True Range (ATR)
- PUBM 0.44
- PSNL 0.35
- MACD
- PUBM 0.21
- PSNL 0.18
- Stochastic Oscillator
- PUBM 67.15
- PSNL 76.35
About PUBM PubMatic Inc.
PubMatic is one of the leading supply-side platform providers in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, better manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). PubMatic generates revenue mainly via taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Given the growth in overall digital advertising, more publishers and advertisers are adopting programmatic (or automated) buying and selling, driving the firm's success in attracting more inventory.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.